albendazole has been researched along with buparvaquone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armson, A; Grubb, WB; Mendis, AH; Reynoldson, JA; Thompson, RC | 1 |
| D'Ascoli, L; Dick, L; Hemphill, A; Hizem, A; Lundström-Stadelmann, B; Ritler, D; Rufener, R; Wells, TNC | 1 |
2 other study(ies) available for albendazole and buparvaquone
| Article | Year |
|---|---|
The efficacy of two electron transport inhibitors (720C80 and 993C76) on murine strongyloidiasis: a comparison with albendazole.
Topics: Albendazole; Animals; Antiprotozoal Agents; Female; Naphthoquinones; Rats; Rats, Sprague-Dawley; Strongyloidiasis | 1993 |
Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Drug Evaluation, Preclinical; Drug Repositioning; Echinococcosis; Echinococcus multilocularis; Electron Transport Complex III; Glucose-6-Phosphate Isomerase; Inhibitory Concentration 50; Life Cycle Stages; Mice; Microscopy, Electron, Transmission; Naphthoquinones; Parasite Load; Phenyl Ethers; Quinolones | 2018 |